The report " Vulvovaginal Candidiasis
- Pipeline Review, H1 2015 provides comprehensive information on the therapeutic development for Vulvovaginal Candidiasis
Keywords: Candida albicans; Grape seed extract; Synergic effect; Amphotericin B; Susceptibility; Disseminated candidiasis
001) and those with a history of oral candidiasis
2) Inhaled steroids also represent a risk for the development of oral, pharyngeal, and laryngeal candidiasis
secondary to local immunosuppression.
Its difficult-to-diagnose status means candidiasis
is often diagnosed as IBS (irritable bowel Beat Candida Cookbook: Over 300 Recipes with a 4-Point Plan for Attacking Candidiasis
, by Erica White (right) is published by Harper Collins, priced pounds 14.
Immunosuppression level in HIV-positive patients with oropharyngeal Candidiasis
Successful treatment with caspofungin of hepatosplenic candidiasis
resistant to liposomal amphotericin B.
In another randomized, double-blind, placebo-controlled trial, women with vulvovaginal candidiasis
received a standard dose of fluconazole plus probiotics (L.
The value of the [beta]-D-glucan assay in diagnosis of invasive candidiasis
has been reviewed.
Glossitis may also be the primary symptom of a fungal infection, such as candidiasis
or viral infection, such as herpes simplex infection.
Atypical and respiratory candidiasis
has also been reported in fowl and raptorial birds.
Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis
The number of spontaneous preterm births was almost three times higher in the women who were not treated for candidiasis
than in those who received treatment (20 births vs.
is a serious hospital-acquired fungal infection that is associated with increased morbidity and mortality in certain immunocompromised patients.
PEV7 is a therapeutic candidate vaccine for the treatment of Recurrent Vulvovaginal Candidiasis
(RVVC), also known as chronic recurrent thrush, a largely unrecognized but highly debilitating condition, which affects 5% of adult women.